Brian Calimlim

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson et al. · The Lancet · 2021 · 502 citations

Allergy, Upadacitinib Versus Placebo, Atopic Dermatitis +9

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Kim Papp, Andrew Blauvelt et al. · JAMA Dermatology · 2022 · 189 citations · Full text

The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life

Bonnie B. Dean, Brian Calimlim, Sylvia L. Kindermann et al. · Journal of Asthma · 2009 · 151 citations

Impact of hidradenitis suppurativa on work loss, indirect costs and income

Thrasyvoulos Tzellos, Hongbo Yang, Fan Mu et al. · British Journal of Dermatology · 2018 · 92 citations · Full text

Contextualizing an expanded definition of health literacy among adolescents in the health care setting

Philip M. Massey, Mike Prelip, Brian Calimlim et al. · Health Education Research · 2012 · 77 citations · Full text